↓ Skip to main content

Protocol for the “Chemobrain in Motion – study” (CIM – study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive…

Overview of attention for article published in BMC Cancer, November 2018
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
322 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Protocol for the “Chemobrain in Motion – study” (CIM – study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy
Published in
BMC Cancer, November 2018
DOI 10.1186/s12885-018-4992-3
Pubmed ID
Authors

Max Oberste, Nils Schaffrath, Katharina Schmidt, Wilhelm Bloch, Elke Jäger, Karen Steindorf, Philipp Hartig, Niklas Joisten, Philipp Zimmer

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 322 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 322 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 54 17%
Student > Bachelor 47 15%
Student > Ph. D. Student 25 8%
Other 19 6%
Student > Postgraduate 16 5%
Other 61 19%
Unknown 100 31%
Readers by discipline Count As %
Nursing and Health Professions 56 17%
Sports and Recreations 48 15%
Medicine and Dentistry 41 13%
Psychology 23 7%
Social Sciences 10 3%
Other 37 11%
Unknown 107 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2018.
All research outputs
#10,931,903
of 13,755,046 outputs
Outputs from BMC Cancer
#3,395
of 5,158 outputs
Outputs of similar age
#233,071
of 307,122 outputs
Outputs of similar age from BMC Cancer
#398
of 641 outputs
Altmetric has tracked 13,755,046 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,158 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,122 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 641 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.